Invesaro

Stocks MRT Financial statements

Financial statements

Marti Technologies, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Marti Technologies, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2022FY2023FY2024FY2025
Revenue17252018.739.2
Cost of revenue1727.124.121.515.3
Gross profit0.04-2.1-4.06-2.8924
Research and development1.041.881.951.963.01
Selling and marketing1.261.657.359.3513
General and administrative6.059.0415.149.228.1
Operating expenses39.748.582.159.3
Operating income-9.05-14.9-30.6-65.3-28.5
Interest income0.182.573.561.411.35
Other non-operating income2.11
Pre-tax income-13.6-14.2-33.8-73.9-41.4
Income tax0.89
Net income-14.5-14.2-33.8-73.9-41.4
EBITDA-3.58-5.78-20.6-56.6-24.9
EPS, basic-0.42-0.32-0.67-1.25-0.53
EPS, diluted-0.42-0.32-0.67-1.25-0.53
Shares, basic (weighted)34.244.150.65978
Shares, diluted (weighted)34.244.150.65978

Balance sheet

FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.6110.519.45.157.81
Receivables0.380.190.20.5
Inventory3.332.612.031.99
Other current assets0.153.573.254.043.64
Total current assets0.7620.525.711.413.9
Property, plant and equipment19.313.55.492.65
Lease right-of-use assets0.840.80.840.91
Intangible assets0.160.180.590.35
Long-term investments0.10.01
Other non-current assets2.0412
Total assets14740.940.220.429.8
Accounts payable0.713.572.81.654.08
Accrued liabilities0.713.150.410.750.54
Deferred revenue1.331.551.852.13
Short-term debt7.2910.44.563.69
Total current liabilities0.7115.917.511.314.4
Long-term debt16.454.870.182.1
Lease liabilities0.670.280.090.14
Other non-current liabilities0.360.330.290.25
Total liabilities5.7433.372.981.896.9
Total debt23.765.374.785.8
Paid-in capital0
Retained earnings-2.03-39.2-65.6-139-181
Treasury stock-0.37
Other comprehensive income-7.56-7.56-7.56-7.56
Shareholders' equity20.57.6-32.7-61.4-67.1
Total equity20.57.6-32.7-61.4-67.1
Total liabilities and equity14740.940.220.429.8

Cash flow statement

FY2021FY2022FY2023FY2024FY2025
Net income-14.5-0.84-33.8-73.9-41.4
Depreciation and amortization5.479.1108.693.59
Stock-based compensation0.871.661.9935.711.3
Change in receivables-0.19-0.210.19-0.02-0.3
Change in inventory-1.75-2.10.660.270.02
Change in payables2.371.66-0.78-1.152.43
Cash from operations-4.04-5.47-14.9-25.1-14.8
Capital expenditures-0.65-0.33-0.49
Cash from investing-22.9-8.16-4.82-1.04-0.54
Stock issued0.17
Share buybacks-0.37
Cash from financing43.111.328.611.818
Exchange rate effect-6.45-0.358.93-14.32.66
Net change in cash9.71-2.728.93-14.32.66
Free cash flow-15.5-25.4-15.3
Interest paid0.180.90.455.287.02
Income taxes paid0.53

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.15 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin61.1%Gross profit / revenue.
Operating margin-72.7%Operating income / revenue.
EBITDA margin-63.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-105.6%Pre-tax income / revenue.
Net margin-105.6%Net income / revenue.
FCF margin-38.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-37.7%Cash from operations / revenue.
Return on assets (ROA)-165.2%Net income / average total assets.
Return on invested capital (ROIC)-237.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue7.7%Research and development expense / revenue.
Stock-based pay / revenue28.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.2%Capital expenditures / revenue.
D&A / revenue9.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y110.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y16.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y46.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-10.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y32.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y21.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.97xCurrent assets / current liabilities.
Quick ratio0.58x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.54x(Cash + short-term investments) / current liabilities.
Debt / assets287.9%Total debt / total assets.
Liabilities / assets325.1%Total liabilities / total assets.
Net debt$78.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital-$449.2KCurrent assets - current liabilities.
Goodwill and intangibles / assets1.2%(Goodwill + intangible assets) / total assets.
Tangible book value-$67.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.56xRevenue / average total assets.
Fixed asset turnover9.63xRevenue / average property, plant and equipment.
Inventory turnover7.59xCost of revenue / average inventory.
Days inventory48 days365 x average inventory / cost of revenue.
Receivables turnover111xRevenue / average receivables.
Days sales outstanding3 days365 x average receivables / revenue.
Days payables69 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-17 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.53Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.53Net income per basic share, as reported (split-adjusted).
Revenue per share$0.50Revenue / diluted weighted shares.
FCF per share-$0.20Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.19Cash from operations / diluted weighted shares.
Book value per share-$0.86Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.86Tangible book value / shares outstanding.
Cash per share$0.10(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$185.0MShare price x shares outstanding.
Enterprise value$263.0MMarket cap + total debt - cash - short-term investments.
P/S4.71xMarket cap / revenue.
EV/Sales6.70xEnterprise value / revenue.
FCF yield-8.3%Free cash flow / market cap.
Earnings yield-22.4%Net income / market cap (the inverse of P/E).
Shareholder yield0.2%(Dividends paid + share buybacks) / market cap.
What was Marti Technologies, Inc.'s revenue in fiscal 2025?

Marti Technologies, Inc. reported revenue of $39.2M for fiscal 2025, 110.3% higher than the year before.

Was Marti Technologies, Inc. profitable in fiscal 2025?

No. It reported a net loss of $41.4M.

How much free cash flow did Marti Technologies, Inc. generate in fiscal 2025?

Cash from operations of $14.8M minus capital expenditures of $485.3K left free cash flow of -$15.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Marti Technologies, Inc.